awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38155855-1C8F50E9-8E69-49E0-AC78-D1B591D28FE3
Q38155855-1C8F50E9-8E69-49E0-AC78-D1B591D28FE3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38155855-1C8F50E9-8E69-49E0-AC78-D1B591D28FE3
The continuing role of chemotherapy for advanced non-small cell lung cancer in the targeted therapy era.
P2860
Q38155855-1C8F50E9-8E69-49E0-AC78-D1B591D28FE3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38155855-1C8F50E9-8E69-49E0-AC78-D1B591D28FE3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
275520db3b4985832cc8c4fd7b26cc45d06fca00
P2860
TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.